• Private Equity Firm

    Shavit Capital is an investment firm that specializes in late-stage investments in Israeli and Israeli-related companies.

    Shavit Capital has over $400 million under management across five separate private equity funds. Shavit Capital was founded in 2008 and the fifth fund was raised in 2018.  The Funds invest in Israeli companies with proven technologies, products, markets and strong management teams. The Funds invest in equity mezzanine or bridge rounds in companies which subsequently expect to raise relatively larger amounts pursuant to an IPO on a major international public exchange or a dual listing of a company that trades on the Tel Aviv Stock Exchange.

    Shavit Capital also invests in other late-stage opportunities, especially through PIPEs (Private Investment in Public Equites) of Israeli publicly-traded companies.

  • Company News

    PolyPid Begins Phase 2 Study in Prevention of Abdominal Surgical Site Infecti
    October 15, 2018
    Mapi Presents Phase II Extension Results of GA Depot
    October 9, 2018
    Gamida Cell to raise $69m in Nasdaq IPO
    October 2, 2018
    Foamix Announces Additional Positive Topline Results from Third Phase III Tri
    October 1, 2018
    Foamix plans $70m offering after acne trial success
    September 13, 2018
    Foamix's Acne Drug Meets Main Goals In Late-Stage Trial
    September 12, 2018
    Foamix jumps on positive Phase III acne trial results
    September 12, 2018
    Gamida Cell files for Nasdaq IPO
    September 2, 2018
    Gamida Cell expands its Orphan Drug Designation from the FDA for NiCord as a
    July 17, 2018
    New Promise for Bone-Marrow Transplants
    May 28, 2018